by user | Jan 2, 2020 | News
2019 was another banner year for precision oncology with the approval of a number of drugs targeting novel genomic alterations, the availability of a third pan-cancer indication, and the commercial launch of new biomarker tests for predicting drug response, such as...
by Jill Mastrianni | Jan 2, 2020 | News
In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...
by user | Dec 27, 2019 | News
Article written by Ellen Matloff for Forbes. Matloff is a regular Forbes contributor, covering genetic counseling, testing, and digital health. The original article can be found here. For years, many of us in the genetics community have strongly suggested...
by Jill Mastrianni | Dec 27, 2019 | News
It’s clear why direct-to-consumer tests for genetic cancer risk are a booming market. At-home tests are relatively affordable, and they offer the appealing possibility of a better understanding of one’s cancer risk on one’s own time, in...
by user | Dec 2, 2019 | News
People around the US, regardless of whether they live in a large city or a remote village, can now order genetic tests online to learn their inherited risks for serious diseases, such as cancer. But what do individuals do after they learn their risks? How do they find...
by Jill Mastrianni | Dec 2, 2019 | News
Direct-to-consumer (DTC) genetic testing has come a long way in popularity, but it still has a long way to go in accuracy. As of February 2019, more than 26 million consumers had tried DTC genetic testing to learn more about their ancestry or uncover genetic...
Recent Comments